Effect of dialysis on plasma total antioxidant capacity and lipid peroxidation products in patients with end-stage renal failure

被引:27
|
作者
Samouilidou, E
Grapsa, E
机构
[1] Alexandra Hosp, Biochem Dept, GR-11528 Athens, Greece
[2] Alexandra Hosp, Renal Unit, GR-11528 Athens, Greece
关键词
hemodialysis; peritoneal dialysis; total antioxidant capacity; malonaldehyde; 4-hydroxyalkenals;
D O I
10.1159/000070691
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Dialysis is associated with an impairment of antioxidant defense and an overproduction of oxidative stress markers. This study focuses on the comparison of plasma total antioxidant capacity (TAC) and lipid peroxidation products in patients on hemodialysis (HD) before and after treatment and in peritoneal dialysis (PD) patients. Plasma TAC, malonaldehyde (MDA), and 4-hydroxyalkenal concentrations were measured in 31 HD patients, in 24 PD patients, and in 17 normal controls (NC). It was found that before HD, TAC and MDA levels were higher than those in the NC (p < 0.001). After HD, these levels decreased significantly but were higher than in NC and lower than in PD patients (p < 0.001). The levels of 4-hydroxyalkenals were elevated in patients as compared with NC, but did not differ between HD and PD patients. The MDA concentrations correlated positively with the TAC in the patients. It is concluded that the oxidative status of patients on HD is similar to that of patients on PD and that the susceptibility to oxidative stress is strongly related to the levels of MDA produced in plasma. Copyright (C) 2003 S. Karger AG, Basel.
引用
收藏
页码:209 / 212
页数:4
相关论文
共 50 条
  • [31] Death and cardiovascular outcomes in end-stage renal failure patients on different modalities of dialysis
    Khoo, Chun Yuan
    Gao, Fei
    Choong, Hui Lin
    Alex, Wei Xian Tan
    Koniman, Riece
    Fam, Jiang Ming
    Yeo, Khung Keong
    ANNALS ACADEMY OF MEDICINE SINGAPORE, 2022, 51 (03) : 136 - 142
  • [32] Obstetric outcomes in women with end-stage renal failure requiring renal dialysis
    Tan, L. -K.
    Kanagalingam, D.
    Tan, H. -K.
    Choong, H. -L.
    INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 2006, 94 (01) : 17 - 22
  • [33] The antioxidant acetylcysteine changes the microheterogeneity of plasma transthyretin in patients with end-stage renal failure into the less amyloidogenic form
    Schweigert, F. J.
    Gericke, B.
    Henze, A.
    Raila, J.
    Wittstock, A.
    Scholze, A.
    Tepel, M.
    ANNALS OF NUTRITION AND METABOLISM, 2007, 51 : 279 - 279
  • [34] Levels of asymmetric dimethylarginine, nitric oxide and lipid peroxidation markers in patients with end-stage renal disease having peritoneal dialysis treatment
    Gocmen, Ayse Yesim
    Sahin, Emel
    Kocak, Hueseyin
    Tuncer, Murat
    Gumuslu, Saadet
    CLINICAL BIOCHEMISTRY, 2008, 41 (10-11) : 836 - 840
  • [35] Effect of Dialysis on Structural Brain Connectivity in Patients with End-Stage Renal Disease
    Choi, Byeongo
    Heo, Chang Min
    Yi, Jiyae
    Lee, Dong Ah
    Lee, Yoo Jin
    Park, Sihyung
    Kim, Yang Wook
    Ko, Junghae
    Park, Bong Soo
    Park, Kang Min
    BLOOD PURIFICATION, 2025, 54 (01) : 28 - 36
  • [36] Plasma total antioxidant capacity, lipid peroxidation, and erythrocyte antioxidant enzyme activities in patients with rheumatoid arthritis and osteoarthritis
    Sarban, S
    Kocyigit, A
    Yazar, M
    Isikan, UE
    CLINICAL BIOCHEMISTRY, 2005, 38 (11) : 981 - 986
  • [37] EFFECT OF DIALYSIS ON PERICARDIAL-EFFUSION - A PROSPECTIVE ECHOCARDIOGRAPHIC STUDY IN END-STAGE RENAL-FAILURE PATIENTS
    YOUNG, JB
    FROMMER, P
    AYUS, C
    ALEXANDER, JK
    MILLER, RR
    CIRCULATION, 1980, 62 (04) : 186 - 186
  • [38] Hypertension in chronic renal failure and end-stage renal disease patients treated with haemodialysis or peritoneal dialysis
    Bianchi, G
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2000, 15 : 105 - 110
  • [39] Plasma thrombopoietin levels in patients with liver cirrhosis, and in patients with end-stage renal failure
    Olsson, A
    Stockelberg, D
    Andersson, PO
    Kutti, J
    Wadenvik, H
    BRITISH JOURNAL OF HAEMATOLOGY, 1998, 102 (01) : 367 - 367
  • [40] PLANNING OF PERMANENT DIALYSIS ACCESS IN END-STAGE RENAL-FAILURE
    CHESSER, AMS
    HURST, MJ
    RAINE, AEG
    BAKER, LRI
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 1995, 6 (03): : 485 - 485